MC
SWAV

Matisse Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Matisse Capital’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,140
Closed -$7.54M – 200
2024
Q1 		$7.54M Sell
23,140
-107
-0.5% -$26.3K 3.62% 4
2023
Q4 		$4.43M Buy
23,247
+1,072
+5% +$203K 2.36% 4
2023
Q3 		$4.42M Buy
22,175
+2,778
+14% +$657K 3.12% 4
2023
Q2 		$5.54M Buy
19,397
+34
+0.2% +$9.44K 3.43% 4
2023
Q1 		$4.2M Buy
19,363
+9,292
+92% +$1.81M 2.71% 4
2022
Q4 		$2.07M Buy
+10,071
New +$2.55M 1.84% 7
2022
Q3 		– Sell
-11,681
Closed -$2.23M – 131
2022
Q2 		$2.23M Buy
11,681
+360
+3% +$63.5K 2.12% 5
2022
Q1 		$2.35M Buy
11,321
+2,690
+31% +$443K 2.16% 8
2021
Q4 		$1.54M Buy
8,631
+545
+7% +$107K 1.06% 22
2021
Q3 		$1.67M Sell
8,086
-20
-0.2% -$3.93K 0.61% 44
2021
Q2 		$1.54M Sell
8,106
-7,686
-49% -$1.26M 0.49% 55
2021
Q1 		$2.06M Buy
15,792
+10,287
+187% +$1.23M 0.59% 55
2020
Q4 		$570K Buy
5,505
+1,470
+36% +$127K 0.18% 93
2020
Q3 		$306K Buy
+4,035
New +$229K 0.12% 108
2019
Q3 		– Sell
-4,370
Closed -$249K – 102
2019
Q2 		$249K Buy
+4,370
New +$212K 0.32% 72

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Matisse Capital's SWAV Position: Q2 2024 in Review

Matisse Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 23,140 shares — an estimated $7.54M sold.

Matisse Capital first reported a position in SWAV in Q2 2019 and held it in 15 quarters. The position peaked at $7.54M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Matisse Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Matisse Capital sold 23,140 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $7.54M.
  • Matisse Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 15 quarters.
  • Matisse Capital's Shockwave Medical, Inc. Common Stock position peaked at $7.54M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Matisse Capital's 13F filing for Q2 2024, filed 30 Jul 2024.